Evidence map›Paper›PMID 42396742›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2025

Aircraft contact investigations for TB on domestic and inbound flights to the United States.

S Swisher, D Weigelt, E Zaborowski, S Gearhart, E Shearer, K Lavilla, A Figueroa, Y Hercules, A M Gertz, C Brown and 1 more

Abstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

S SwisherDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA;, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
D WeigeltDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
E ZaborowskiDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
S GearhartDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
E ShearerDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA;, Applied Epidemiology Fellowship Program, Council of State and Territorial Epidemiologists, Atlanta, GA, USA.
K LavillaDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
A FigueroaDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Y HerculesDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
A M GertzDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
C BrownDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
S MaseDivision of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

<sec><title>BACKGROUND</title>U.S. Centers for Disease Control and Prevention (CDC) coordinates contact investigations (CIs) for TB exposures on commercial flights when criteria are met. Aircraft CIs are resource-intensive and require collaboration with health departments (HDs). Post-exposure TB assessments are challenging as multiple follow-up visits are needed. Evidence supporting TB transmission on aircraft is limited.</sec><sec><title>METHODS</title>TB aircraft CI outcomes data submitted to CDC by HDs from 24 June 2011 to 31 December 2022 were analysed using descriptive statistics to summarise outcomes, risk factors for prior exposure, timing of diagnosis, and data completeness.</sec><sec><title>RESULTS</title>Of 15,043 contacts identified, final determination of TB status was available for 2,282/15,043 (15%). Of these, 3/2,282 (0.1%) had TB disease and 366/22,282 (16%) had TB infection (TBI). Most (78%) contacts with TB had other exposure risk factors. Ten exhibited conversion on serial testing within 4 months after the flight, indicating recent infection. All contacts with TB disease and 44 with TBI (14% of those with test dates available) were tested before HDs were notified of aircraft exposure.</sec><sec><title>CONCLUSION</title>TB aircraft CIs identified persons with TB disease or TBI; however, most had TB risk factors other than aircraft exposure. The low return of outcomes was a limitation for formulating robust recommendations.</sec>.

Indexed as

AircraftContact TracingTuberculosisAir TravelCenters for Disease Control and Prevention, U.S.HumansRisk FactorsUnited States

Identifiers

PMID42396742
PMCPMC13336237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.